Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease (Q35588726)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 March 2015

Language	Label	Description	Also known as
English	Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease	scientific article published on 12 March 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

Stefanie Sarantopoulos

13

object named as

Stefanie Sarantopoulos

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Steven Z. Pavletic

8

object named as

Steven Z Pavletic

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

object named as

Leora E Comis

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Kristin Baird

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Galen O Joe

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Seth M Steinberg

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Fran T Hakim

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jeremy J Rose

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sandra A Mitchell

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

William D Figg

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Lawrence Yao

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Kathleen C Flanders

11

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Naoko Takebe

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Susan Booher

14

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Edward W Cowen

15

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1083-1090

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Extracorporeal photopheresis in acute and chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Assessing Dexterity Function: A Comparison of Two Alternatives for the NIH Toolbox

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Imatinib and the Treatment of Fibrosis: Recent Trials and Tribulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

27 July 2018

Assessment of joint and fascia manifestations in chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Increased BCR responsiveness in B cells from patients with chronic GVHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Psychometric validation of the Manual Ability Measure-36 (MAM-36) in patients with neurologic and musculoskeletal disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Validity and responsiveness of the Jebsen-Taylor Hand Function Test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Imatinib for refractory chronic graft-versus-host disease with fibrotic features.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

The Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) can measure the impairment, activity limitations and participation restriction constructs from the International Classification of Functioning, Disability and Health (ICF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Pentoxifylline in the treatment of radiation-induced fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

26 September 2018

Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4425991

15 November 2018

Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UVA1 therapy for sclerodermic graft-versus-host disease of the skin

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of a scale to measure symptoms of chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maximum oxygen consumption and the ADAPT quality-of-life scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability and validity of grip and pinch strength evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of platelet-derived growth factor type b receptors in the skin of patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of using the Assessment of Motor and Process Skills to determine the need for assistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology

1 reference

https://pubmed.ncbi.nlm.nih.gov/25771402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2015.03.006

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35588726&oldid=2088864466"